Aprea Therapeutics
APRE
#11017
Rank
NZ$11.3 M
Marketcap
NZ$0.80
Share price
-11.06%
Change (1 day)
-64.59%
Change (1 year)

Market capitalization of Aprea Therapeutics (APRE)

Market cap: NZ$11.3 Million

As of November 2026 Aprea Therapeutics has a market cap of NZ$11.3 Million. This makes Aprea Therapeutics the world's 11017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aprea Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$11.3 M-4.48%
2025NZ$11.83 M-63.55%
2024NZ$32.47 M16.94%
2023NZ$27.77 M0.51%
2022NZ$27.62 M-69.37%
2021NZ$90.19 M-37.57%
2020NZ$0.14 B-89.9%
2019NZ$1.43 B

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Aprea Therapeutics was reported to be:

NZ$11.3 Million
by Nasdaq info icon info icon
NZ$11.3 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Magellan Health
MGLN
NZ$4.47 B 39,454.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
NZ$5.93 B 52,423.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
NZ$3.05 B 26,878.90%๐Ÿ‡บ๐Ÿ‡ธ USA